Resmed Inc DRC
Research Resmed Inc DRC (RMEA) on Bullrun: market cap EUR 27.41B, P/E 21.3, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRMEA
- ExchangeF
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 27.41B
- P/E21.3
- Dividend yield0.8%
- Financial periodQ1 2026
- RevenueUSD 1.43B
- Net incomeUSD 398.73M
- Free cash flowUSD 514.54M
- Gross margin62.2%
Valuation Snapshot
latest market cap is EUR 27.41B; P/E is 21.3; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 21.35x versus a Healthcare sector median of 24.46x (12.7% below).
Latest dividend yield is 0.79% versus a Healthcare sector median of 2.11% (62.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 5.40B | USD 1.49B | USD 1.78B | 60.9% | n/a | USD 1.42B | USD 847.72M | USD 6.32B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 27.41B | 21.3 | 1.2% | 0.23 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.23 EUR, yield 0.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.2 USD |
About Resmed Inc DRC
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Resmed Inc DRC's market cap?
Resmed Inc DRC's market capitalization is EUR 27.41B.
What is Resmed Inc DRC's P/E ratio?
Resmed Inc DRC's price-to-earnings (P/E) ratio is 21.3.
Does Resmed Inc DRC pay a dividend?
Resmed Inc DRC has a dividend yield of 0.8%.
What does Resmed Inc DRC do?
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.